STERIS (STE) Q4 2024 Annual Earnings
STE·Reported May 8, 2024·After market close
STERIS reported Q4 2024 revenue of $1.4B, beat analyst consensus of $1.4B by $8.0M. Diluted EPS came in at $2.41, beat the $2.35 consensus by $0.06. STERIS reports across 3 business segments, led by Healthcare, Applied Sterilization Technologies (AST), and Life Sciences.
Revenue
$1.4Bbeat by $8.0M
Consensus: $1.4BDiluted EPS
$2.41beat by $0.06
Consensus: $2.35
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about STERIS's Q4 2024 earnings report.
STERIS (STE) reported Q4 2024 earnings on May 8, 2024 after market close.
STERIS reported revenue of $1.4B and diluted EPS of $2.41 for Q4 2024.
Revenue beat the consensus estimate of $1.4B by $8.0M. EPS beat the consensus estimate of $2.35 by $0.06.
You can read the 10-K periodic report (0001757898-24-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.